[Kawasaki disease epidemiology in Guadeloupe].
OBJECTIVE
To study the incidence of Kawasaki disease in the population of the French West Indies.


METHODS
Fifty-six children where enrolled between January 1, 1995 and December 31, 2000), in this retrospective study in Guadeloupe (French West Indies), according to the diagnostic criteria of the American Heart Association.


RESULTS
There were 31 boys and 25 girls. Their mean age at the time of diagnosis was 26.5 +/- 22 months. The mean incidence was 25.4/100 000 children aged under 5, per year. Cardiac involvement was noted in 17.8% of the cases during the first 3 months, with good outcome in all the children followed-up.


CONCLUSIONS
The incidence of Kawasaki disease in Guadeloupe is high. The absence of epidemiological, clinical or biological predictive criteria of cardiac involvement should prompt the early use of immunoglobulins, notably in atypical presentations of the disease.
Tourneux
Pierre
P
Service de médecine néonatale et réanimation pédiatrique polyvalente, Hôpital Nord, CHU Amiens. pierre_tourneux@hotmail.com
Dufillot
Denis
D
Belloy
Marie
M
Boralevi
Franck
F
Cevallos
Lorena
L
Krim
Gérard
G
D017677:Age Distribution; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004452:Echocardiography; D005260:Female; D005334:Fever / Q000209:etiology; D019430:Guadeloupe / Q000453:epidemiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D015994:Incidence; D007223:Infant; D007964:Leukocytosis / Q000209:etiology; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D018579:Patient Selection; D011159:Population Surveillance; D012189:Retrospective Studies; D012307:Risk Factors; D012621:Seasons; D017678:Sex Distribution; D013922:Thrombocytosis / Q000209:etiology; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016756:Immunoglobulins, Intravenous; D001241:Aspirin